Advisory Shares: Why 90% of Them Are Worth Nothing (And When to Take the Deal)
Advisory Shares: Why 90% of Them Are Worth Nothing (And When to Take the Deal) Run the math. A pre-seed advisory grant of 0.225% equity, at a startup with a 15% chance of surviving, sold at a 6x exit multiple on a $1M...
Advisory Shares: Why 90% of Them Are Worth Nothing (And When to Take the Deal)
Run the math. A pre-seed advisory grant of 0.225% equity, at a startup with a 15% chance of surviving, sold at a 6x exit multiple on a $1M seed valuation — that's $2,025 before taxes. That's three hours of any senior advisor's time at market rate. Most advisors never see a dime. Most founders never stop to do this calculation before signing.
The Problem Nobody Wants to Say Out Loud
Advisory equity is broken. Founders hand it out like business cards at a conference. Advisors collect it like lottery tickets in a drawer. Neither party does the math, and the result is a cap table littered with 0.25% stakes tied to people who showed up for two calls in 2022 and then went quiet.
I've watched this happen across dozens of deals. A founder gets excited about landing a well-known operator as an advisor. They grant 0.5%, skip the vesting cliff, and write "general strategic support" in the agreement. Nine months later the advisor hasn't responded to an email in six weeks, the founder is embarrassed to follow up, and that 0.5% sits permanently diluting the cap table. No investor who reads it will say anything nice.
The conventional wisdom on advisory shares goes like this: equity is cheap at an early stage, advisors bring relationships and credibility, and the FAST Agreement makes it easy. None of that is wrong. All of it together creates a permission structure for lazy decision-making on both sides.
How Advisory Shares Actually Work — With Real Numbers
Advisory shares are typically restricted stock awards or non-qualified stock options granted to outside advisors. They vest over a shorter timeline than employee equity — usually two years with a three-month cliff and monthly vesting thereafter — to reflect the part-time, front-loaded nature of most advisory relationships.
The Founder Institute's FAST Agreement, first released in 2011 and updated in August 2017, standardized this into a one-page template. The equity matrix works like this:
- Idea stage, standard engagement (monthly meetings): 0.25%
- Idea stage, strategic engagement (add recruiting): 0.50%
- Idea stage, expert engagement (customer/investor intros, projects): 1.00%
- Startup stage rates drop to 0.20%, 0.40%, 0.80%
- Growth stage drops again to 0.15%, 0.30%, 0.60%
The FAST framework did the industry a genuine service by reducing legal friction. A clean agreement that would have cost $3,000 in lawyer time now costs nothing. But standardization created a different problem: founders treat the template as a floor instead of a ceiling. "The FAST Agreement says 0.25%" became the default justification for grants that should never have happened.
Here's what the actual expected value looks like across outcomes. Take a 0.5% pre-seed advisory grant at a $1M seed valuation:
- Strong exit (10x): $50,000 gross, roughly $30,000–35,000 after taxes and holding costs
- Zombie exit (2x acqui-hire): $10,000 gross, about $6,000–7,000 net
- Failure (85% probability): $0, and potentially a tax bill if you filed the 83(b)
Probability-weighted, that 0.5% pre-seed grant is worth roughly $4,500 in expected value. If you're an advisor billing $300/hour, you just traded fifteen hours of consulting work — minimum — for a lottery ticket with an expected payout of $4,500. Spread over two years of vesting, that's approximately nothing.
The 83(b) Trap That Nobody Explains Until It's Too Late
This is where advisory shares stop being merely low-value and start being genuinely dangerous.
When you receive restricted stock that vests over time, the IRS taxes you at ordinary income rates when each tranche vests — based on the fair market value at that point. If the company raised a Series A at a $10M valuation between your grant and your vesting date, you owe income tax on the appreciated value even though you can't sell the shares yet.
Section 83(b) of the IRC offers an escape: file an election within 30 days of the grant, pay tax on the value at grant (usually near zero at pre-seed), and lock in capital gains treatment for everything that appreciates afterward. It sounds like an obvious move. Most advisors and founders treat it as routine paperwork.
Here's where it goes sideways. The 83(b) election is irrevocable. If you file it and the company fails before your shares vest, you paid ordinary income tax on shares that are now worthless. You get no refund. You cannot deduct the loss dollar-for-dollar against the tax you already paid on the grant. You're out both the equity and the tax.
The 30-day deadline is a hard stop. Miss it by a day and you lose the election permanently — you'll owe ordinary income tax on every vesting tranche at whatever the FMV is at that time. Attorneys who specialize in startup equity call this one of the most common and most expensive mistakes they see from first-time advisors.
My read: if a founder asks you to sign a restricted stock advisory agreement, get a tax advisor on the phone before you sign anything. The 83(b) clock starts at grant, not at the moment you read the email attachment. Budget one hour of CPA time. It costs less than the tax mistake you're trying to avoid.
Five Red Flags That Mean You Walk Away
I've seen enough bad advisory deals to give you a short list of situations where the answer is no.
No vesting schedule. Fully vested advisory shares on day one mean the advisor can disappear the following week and keep everything. There is no clawback. The founder has no recourse. Any advisor who pushes back on a two-year vesting schedule is telling you something important about their intentions.
No defined role or deliverables. "General strategic guidance" is not a deliverable. Neither is "available for calls as needed." If a founder cannot articulate three to five specific things an advisor will do — introductions to five named customer prospects by month four, monthly product feedback sessions, a warm intro to two Series A leads by month six — there is no basis for an equity grant. The relationship is a handshake with a lottery ticket attached.
An investor asking for advisory shares on top of their investment. This is a double-dip. The investor already has equity upside from their check. Chris Neumann put it plainly: asking for advisory shares as a condition of investment is not standard, not appropriate, and not acceptable in any credible tech environment. If someone presents this as routine, they're either misinformed or testing whether you'll push back. Push back.
The advisor is advising ten or more other startups simultaneously. Your startup becomes a line item on their advisory portfolio. Attention is finite. I've seen this pattern enough times to know that advisors running large portfolios of advisory stakes are optimizing for the portfolio, not for any individual company. Run a two-to-three month trial with no equity commitment before signing anything.
Total advisory pool already above five percent. Investors notice this immediately. Five advisors at one percent each equals five percent of your cap table before you've hired employee number one. Above eight percent total advisory equity, you're signaling to every institutional investor that the founder cannot say no to people who flatter them. Cap the advisory pool at three to five percent total, and treat that ceiling as a constraint from day one.
What I'd Demand Before Signing
If the deal clears the red flag checklist and the math makes sense in a strong outcome scenario, here's what I'd require before any equity changes hands.
First, use the FAST Agreement or a counsel-drafted equivalent. Budget $1,000–2,000 for a clean document if you're not using FAST. Verbal advisory arrangements are unenforceable. You need written vesting terms, termination rights, IP assignment, and confidentiality — in writing, signed by both parties.
Second, require a two-year vesting schedule with a three-to-six month cliff. This is non-negotiable. The cliff protects the founder if the relationship doesn't click. Monthly vesting thereafter keeps the advisor engaged over time. Any advisor who argues against standard vesting terms is not the right advisor.
Third, define specific deliverables with dates. Not "introductions to customers" — "introductions to at least four enterprise software buyers in the healthcare vertical by month three." Measurable outcomes align incentives in ways that general language never will.
Fourth, run a trial before you grant equity. Engage informally for sixty to ninety days. See if the advisor shows up consistently, responds within twenty-four hours, and actually produces value. I've ended more than a few would-be advisory relationships during trial periods because the person who seemed sharp in the first meeting had a completely different level of engagement once there was no equity on the table yet. That trial period tells you everything.
Fifth, include a clean termination clause. Either party exits with thirty days' notice. The advisor keeps vested shares; unvested shares return to the pool automatically. No re-negotiation, no drama, no lingering obligation. Clean exits protect both sides.
For advisors on the receiving end: understand the 83(b) election before you sign. Know that 0.25% at pre-seed has an expected value around $2,000–4,500 based on realistic success probabilities. If you don't believe enough in the founder to write a $10,000–25,000 angel check alongside the advisory equity, ask yourself why you're betting your time instead of your money. The answer to that question will tell you more about the deal than any term sheet will.
Advisory shares work when both sides treat the relationship as a real commitment with real accountability. That means written agreements, vesting schedules with teeth, defined deliverables, and honest conversations about what the equity is actually worth. Most advisory relationships never get that serious. That's exactly why most advisory shares are worth nothing.
Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.
This article is for informational and educational purposes only and does not constitute investment, legal, or tax advice. Always consult a qualified financial advisor, attorney, or tax professional before making investment decisions.
Topics
Looking for investors?
Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.
About the Author
Jeff Barnes, MBA